Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 +0.03 (+7.30%)
As of: Oct 23, 2026 · 3:59 PM EDT

Citius Pharmaceuticals (CTXR) Gross Profit (2025 - 2026)

Updated

Citius Pharmaceuticals (CTXR) recorded Gross Profit of $1 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 25.1% from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Gross Profit (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Citius Pharmaceuticals 10.47 Mn -23.10 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2026 1.34 Mn
Dec 31, 2025 3.15 Mn
API Access

Citius Pharmaceuticals Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CTXR&period=max&api_key=YOUR_API_KEY